# Adam Azzara

> Adam Azzara is the CEO of DuraStat, an Austin-based medical device company built around a precision suturing technology that helps neurosurgeons repair dural tears during spine surgery. He rose from VP of sales and marketing to chief executive, took the flagship product to all 50 states with more than 10,000 units distributed, closed a Series B, secured a Premier breakthrough technology agreement, and in 2024 landed an exclusive U.S. commercial partnership with Medtronic. His pitch is disarmingly plain: give surgeons simple, cost-effective tools for problems they face every day.

- **Role:** CEO at DuraStat
- **Organizations:** DuraStat
- **Nationality:** American
- **Education:** Business (Students In Free Enterprise; SDSU Small Business Consulting), San Diego State University
- **Known for:** Led DuraStat's flagship dural repair product to distribution in all 50 U.S. states, surpassing 10,000 units, Closed a Series B financing round of more than $5 million in 2022, Secured a Breakthrough Technology Agreement with Premier, Inc. in 2023

## Career timeline

- **2020** — Joined DuraStat as Vice President of Sales and Marketing
- **2022** — Became Chief Executive Officer of DuraStat
- **2022** — Closed Series B financing of over $5 million; relocated headquarters to Austin, Texas
- **2023** — DuraStat awarded a Breakthrough Technology Agreement with Premier, Inc.
- **2024** — Signed exclusive U.S. commercial partnership with Medtronic's Cranial & Spinal Technologies business; surpassed 10,000 units distributed across all 50 states

## Achievements

- Led DuraStat's flagship dural repair product to distribution in all 50 U.S. states, surpassing 10,000 units
- Closed a Series B financing round of more than $5 million in 2022
- Secured a Breakthrough Technology Agreement with Premier, Inc. in 2023
- Negotiated an exclusive U.S. commercial partnership with Medtronic in 2024
- Advanced a second-generation DuraStat device and the TissueStat fascial closure product toward launch

## Latest updates

- **2024-11** — DuraStat launched an exclusive U.S. commercial partnership with Medtronic's Cranial & Spinal Technologies business ahead of second-generation DuraStat and full-scale TissueStat launches.

## Links

- Website: https://durastat.com
- LinkedIn: http://www.linkedin.com/in/adamazzara

---

Profile page: https://yespress.io/adam-azzara
Published by YesPress — https://yespress.io
Last updated: 2026-08-06